Yes , your company has a very good advisers , Dr Fauci and Gilead , and they even accomplished approval for this drug , Remdesivir..Go figure...
IMO Lenzilumab is much better then that , not as good as Leronlimab , but much better then Remdesivir..
You will have EUA VERY fast ... your friends will make sure of that .
And if CYDY will change once primary endpoint from mortality to length of hospitalization , we are SS , about 0.005 p-value..Go figure ...
And all MO..